|
|
|
|
Total Scores
|
Combined Scores
|
|
|
|
|
Lay
|
Provider
|
Weighted Additive Scores
|
Weighted Multiplicative Scores
|
|
Pathogen
|
Vaccine Envisaged
|
Target Population
|
Weighted Additive
|
Weighted Multiplicative (×10−6)
|
Weighted Additive
|
Weighted Multiplicative (×10−6)
|
Additive
|
Multiplicative
|
Additive (×10−6)
|
Multiplicative (×10−72)
|
|
Herpes simplex viruses 1 & 2
|
Glycoprotein produced by recombinant DNA technology
|
Children up to age 12 and other susceptibles
|
14
|
0.61
|
18
|
1.54
|
32
|
252
|
2.15
|
0.9394
|
|
|
Attenuated live virus
|
Children up to age 12 and other susceptibles
|
14
|
0.61
|
12
|
0.56
|
26
|
168
|
1.17
|
0.3416
|
|
Herpesvirus varicellae
|
Attenuated live virus
|
Recipients of organ and bone marrow transplants and persons under age 25 with leukemias and lymphomas
|
41
|
35.42
|
33
|
13.43
|
74
|
1353
|
48.85
|
475.6906
|
|
|
|
Normal susceptibles, routine for children (booster for adults)
|
24
|
2.25
|
18
|
0.56
|
42
|
432
|
2.81
|
1.26
|
|
Influenza viruses A & B
|
Subunit vaccine (purified hemagglutinin/ neuraminidase proteins)
|
High-risk population as currently defined (see Appendix K)
|
10
|
0.35
|
16
|
1.07
|
26
|
160
|
1.42
|
0.3745
|
|
|
Attenuated live virus
|
High-risk population as currently defined (see Appendix K)
|
13
|
0.6
|
16
|
1.07
|
29
|
208
|
1.67
|
0.642
|
|
Neisseria gonorrhoeae
|
A small number of promising options need investigation to determine best approach
|
Adolescents and adults age 15 and over
|
5
|
0.085
|
15
|
0.66
|
20
|
75
|
0.745
|
0.0561
|
|
Parainfluenza viruses
|
Trivalent, subunit vaccine (must contain fusion protein)
|
Infants
|
19
|
0.68
|
25
|
4.74
|
44
|
475
|
5.42
|
3.2232
|
|
Respiratory syncytial virus
|
Glycoprotein produced by recombinant DNA technology
|
Infants
|
12
|
0.41
|
19
|
1.7
|
31
|
228
|
2.11
|
0.697
|
|
|
Attenuated live virus
|
Infants
|
18
|
1.38
|
21
|
2.3
|
39
|
378
|
3.68
|
3.174
|
|
Rotavirus
|
Attenuated live bovine virus
|
Infants
|
14
|
0.64
|
17
|
0.68
|
31
|
238
|
1.32
|
0.4352
|
|
|
Attenuated live human or reassortment virus
|
Infants
|
14
|
0.64
|
17
|
0.68
|
31
|
238
|
1.32
|
0.4352
|
|
Streptococcus group B
|
Conjugated polysaccharide
|
Pregnant women for fetuses and neonates
|
6
|
0.041
|
20
|
1.57
|
26
|
120
|
1.611
|
0.06437
|
